Back to Rankings

INO

InovioD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
INO vs peer average
38/100
INO vs. peer average (D vs. C)
Grade spread
A 1 · B 2 · C 1 · D 2 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

KLRS is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $106.96M

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerKLRSKalaris Therapeutics
INO
Inovio
KLRS
Kalaris Therapeutics
Grade
D
B
Momentum
40
74
Value
41
42
Sentiment
-
67
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive

Grade position vs KLRS

INO / KLRS
Grade Position
Below peers
INO vs. peer average (D vs. C)
38/100
Momentum
40
KLRS
Value
41
KLRS
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs INO
1
KLRS
Kalaris Therapeutics Inc Common
B
80/100
-2
2
SEER
Seer Inc Class A Common
F
20/100
+1
3
OTLK
Outlook Therapeutics Inc Common
F
20/100
+1
4
PEPG
PepGen Inc Common
C
60/100
-1
5
VRCA
Verrica Pharmaceuticals Inc Common
D
40/100
Even
KLRS is the first peer returned for this comparison set.